http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109925315-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109925315-B |
| titleOfInvention | Use of cyclic tyrosine-valine and analogues thereof for the treatment of asthma and respiratory allergies |
| abstract | The invention provides an application of cyclic tyrosine-valine and analogues thereof in treating asthma and respiratory tract allergy. The cyclic tyrosine-valine is a dipeptide compound which can reduce Th2 cell activation, airway hyperreactivity, immune cell accumulation in bronchoalveolar fluid, and antigen-specific antibody production in animal or human subjects, and thus, it can be used for the treatment of asthma and airway allergy. |
| priorityDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.